Bristol Myers Squibb BMY
NYSE BMY
$61.14 +2.31 (+3.93%)
As of: Oct 20, 2026 · 10:21 AM EDT

Bristol Myers Squibb (BMY) Capital Expenditures (2009 - 2026)

Updated

Bristol Myers Squibb's Capital Expenditures came in at $305 million for Q2 2026, down 15.5% from $361 million a year earlier and down 12.1% from the prior quarter.

Analysis

Bristol Myers Squibb (BMY) Capital Expenditures (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Bristol Myers Squibb reported Capital Expenditures of $1.34 billion, up 1.4% year-over-year; for FY2025, it was $1.31 billion, up 5.0% from FY2024.

  • Capital Expenditures has increased in each of the last five years, with a five-year compound annual growth rate of 11.7% (FY2020 to FY2025).
  • Going back by year, Capital Expenditures was $1.25 billion in FY2024 (+3.2%), $1.21 billion in FY2023 (+8.1%), $1.12 billion in FY2022 (+14.9%) and $973 million in FY2021 (+29.2%).
  • The Q2 2026 figure represents the lowest quarterly Capital Expenditures since Q1 2025.
  • Year-over-year, Capital Expenditures increased in three of the last eight quarters, with growth averaging 6.7%.
  • The fastest year-over-year change in Capital Expenditures over five years came in Q3 2021 (growth of 76.5%), and the weakest in Q2 2026 (a decline of 15.5%).
  • Business Quant data shows BMY's Capital Expenditures at $347 million (Q1 2026), $370 million (Q4 2025) and $320 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,164.60 Bn 1,133.19 Bn 19.71 Bn 2.93 Bn
2 Johnson & Johnson 624.86 Bn 543.39 Bn 17.26 Bn 1.32 Bn
3 AbbVie 509.50 Bn 482.61 Bn 12.70 Bn 322.00 Mn
4 Merck 366.62 Bn 321.00 Bn 12.21 Bn 893.00 Mn
5 Novartis Ag 295.95 Bn 259.94 Bn 11.24 Bn 321.00 Mn
6 Astrazeneca 260.20 Bn 233.88 Bn 12.86 Bn 1.86 Bn
7 Amgen 234.89 Bn 190.29 Bn 7.24 Bn 513.00 Mn
8 Gilead Sciences 192.98 Bn 167.17 Bn 6.22 Bn 140.00 Mn
9 Pfizer 170.69 Bn 117.33 Bn 10.94 Bn 533.00 Mn
10 Bristol Myers Squibb 124.50 Bn 75.77 Bn 9.25 Bn 305.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 305.00 Mn
Mar 31, 2026 347.00 Mn
Dec 31, 2025 370.00 Mn
Sep 30, 2025 320.00 Mn
Jun 30, 2025 361.00 Mn
Mar 31, 2025 260.00 Mn
Dec 31, 2024 378.00 Mn
Sep 30, 2024 324.00 Mn
Jun 30, 2024 262.00 Mn
Mar 31, 2024 284.00 Mn
Dec 31, 2023 330.00 Mn
Sep 30, 2023 342.00 Mn
Jun 30, 2023 259.00 Mn
Mar 31, 2023 278.00 Mn
Dec 31, 2022 346.00 Mn
Sep 30, 2022 247.00 Mn
Jun 30, 2022 272.00 Mn
Mar 31, 2022 253.00 Mn
Dec 31, 2021 320.00 Mn
Sep 30, 2021 270.00 Mn
API Access

Bristol Myers Squibb Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=BMY&period=max&api_key=YOUR_API_KEY